Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
54.20
-0.06 (-0.11%)
At close: Oct 31, 2025, 4:00 PM EDT
54.50
+0.30 (0.55%)
After-hours: Oct 31, 2025, 4:39 PM EDT
Akero Therapeutics Market Cap
Akero Therapeutics has a market cap or net worth of $4.34 billion as of October 31, 2025. Its market cap has increased by 109.09% in one year.
Market Cap
4.34B
Enterprise Value
3.30B
1-Year Change
109.09%
Ranking
Category
Stock Price
$54.20
Market Cap Chart
Since June 20, 2019, Akero Therapeutics's market cap has increased from $495.47M to $4.34B, an increase of 776.94%. That is a compound annual growth rate of 40.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 4.35B | 124.00% |
| Dec 31, 2024 | 1.94B | 49.28% |
| Dec 29, 2023 | 1.30B | -49.24% |
| Dec 30, 2022 | 2.56B | 247.29% |
| Dec 31, 2021 | 737.89M | -17.63% |
| Dec 31, 2020 | 895.82M | 41.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.66B |
| Johnson & Johnson | 455.50B |
| AbbVie | 385.27B |
| UnitedHealth Group | 309.47B |
| AstraZeneca | 255.76B |
| Novartis AG | 236.67B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.94B |